Suma Krishnan Krystal Biotech, Inc. (KRYS) insider trading activity

Suma Krishnan is President, R&D of Krystal Biotech, Inc.. Currently has a direct ownership of 1.44 Million shares of KRYS, which is worth approximately $216 Million. The most recent transaction as insider was on Jul 16, 2025, when has been sold 1,529 shares (Common Stock) at a price of $150.0 per share, resulting in proceeds of $229,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.44M

1.71% 3M change

5.71% 12M change

Total Value Held $216 Million

Suma Krishnan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 16 2025	SELL Open market or private sale	$229,350 $150.0 p/Share	1,529 Reduced 0.11%	1,438,711 Common Stock
Jul 15 2025	SELL Open market or private sale	$459,134 $151.23 p/Share	3,036 Reduced 0.21%	1,440,240 Common Stock
Jul 14 2025	SELL Open market or private sale	$2,023,848 $150.64 p/Share	13,435 Reduced 0.92%	1,443,276 Common Stock
Jul 10 2025	SELL Open market or private sale	$1,025,508 $150.81 p/Share	6,800 Reduced 0.46%	1,456,711 Common Stock
Jul 09 2025	SELL Open market or private sale	$30,027 $150.14 p/Share	200 Reduced 0.01%	1,463,511 Common Stock
Mar 13 2025	SELL Open market or private sale	$4,444,000 $177.76 p/Share	25,000 Reduced 1.68%	1,463,711 Common Stock
Feb 28 2025	SELL Payment of exercise price or tax liability	$2,488,886 $179.25 p/Share	13,885 Reduced 0.92%	1,488,711 Common Stock
Feb 28 2025	BUY Exercise of conversion of derivative security	-	30,000 Added 1.96%	1,499,125 Common Stock
Feb 26 2025	SELL Payment of exercise price or tax liability	$579,617 $176.39 p/Share	3,286 Reduced 0.22%	1,472,596 Common Stock
Dec 13 2024	SELL Open market or private sale	$4,179,000 $167.16 p/Share	25,000 Reduced 1.67%	1,475,882 Common Stock
Sep 12 2024	SELL Open market or private sale	$4,959,500 $198.38 p/Share	25,000 Reduced 1.64%	1,500,882 Common Stock
Jun 11 2024	SELL Open market or private sale	$4,371,250 $174.85 p/Share	25,000 Reduced 1.61%	1,525,882 Common Stock
Mar 11 2024	SELL Open market or private sale	$4,279,500 $171.18 p/Share	25,000 Reduced 1.59%	1,550,882 Common Stock
Feb 28 2024	SELL Payment of exercise price or tax liability	$566,050 $163.08 p/Share	3,471 Reduced 0.22%	1,575,882 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	-	7,500 Added 0.47%	1,579,353 Common Stock
Feb 26 2024	SELL Payment of exercise price or tax liability	$369,421 $157.0 p/Share	2,353 Reduced 0.15%	1,571,853 Common Stock
Dec 11 2023	SELL Open market or private sale	$2,644,000 $105.76 p/Share	25,000 Reduced 1.56%	1,574,206 Common Stock
Sep 11 2023	SELL Open market or private sale	$3,180,250 $127.21 p/Share	25,000 Reduced 1.54%	1,599,206 Common Stock
May 31 2023	SELL Open market or private sale	$2,920,000 $116.8 p/Share	25,000 Reduced 1.52%	1,624,206 Common Stock
Apr 17 2023	SELL Open market or private sale	$2,186,500 $87.46 p/Share	25,000 Reduced 1.49%	1,649,206 Common Stock
Feb 26 2023	SELL Payment of exercise price or tax liability	$239,852 $78.46 p/Share	3,057 Reduced 0.18%	1,674,206 Common Stock
Jan 18 2023	SELL Open market or private sale	$231,439 $81.15 p/Share	2,852 Reduced 0.17%	1,677,263 Common Stock
Jan 17 2023	SELL Open market or private sale	$1,807,498 $81.61 p/Share	22,148 Reduced 1.3%	1,680,115 Common Stock
Jan 04 2023	SELL Open market or private sale	$315,394 $80.09 p/Share	3,938 Reduced 0.23%	1,702,263 Common Stock
Jan 03 2023	SELL Open market or private sale	$136,561 $80.33 p/Share	1,700 Reduced 0.1%	1,706,201 Common Stock

Suma Krishnan

President, R&D

Pittsburgh, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRYS shares.

Notify only if

Value

Insider Trading

Get notified when an Krystal Biotech, Inc. insider buys or sells KRYS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Krystal Biotech, Inc.

Track Activities on KRYS

Account